Immune and Cell Support for Cancer Patients
Authentic AVEMAR™ Products
AVEMAR™ is supplementing oncological treatments WORLDWIDE since 1998
Buy more & SAVE up to 20%
Positive impacts
on quality of life for oncological patients
All-natural
supplement to support the ongoing treatments
Clinically proven
to improve the efficacy of cancer treatments and immunotherapy
Free U.S. delivery
with express shipping to your door in 2-4 business days
Avemar is ALL NATURAL
The active ingredient in Avemar products is Avemar Pulvis, made from high-quality wheat germ through biotechnological transformation. Wheat germ is an extremely spermidine-rich, oil-rich plant part, the patented extract of which is prepared by fermentation.
In the US, Avemar has been affirmed as GRAS (generally recognized as safe) in accordance with the FDA (Food & Drug Administration) procedure, a certification of the safety of food ingredients. Thus, the products are considered as safe, and can be used in any stage of the malignant disease.
Customer Testimonials
What is AVEMAR?
Avemar is an all-natural, clinically proven supplement for cancer patients. Medical experts recognize it as an effective supportive cancer treatment and recommend complementing the diet of concerned patients with Avemar.
Scientific studies showed that Avemar also enhances the efficacy of conventional oncological treatments (surgery, radio-, chemo- and immunotherapy). With regular intake of the products, patients can relish a better quality of life and can enjoy a better lifestyle. Avemar is available in drink powder and film-coated tablet forms.
Numerous scientific studies have been conducted to study Avemar’s safety profile and its effectiveness, including in vitro, in vivo and human clinical research. Over 150 reports have been written for presentation or publication since 1998, and over 40 peer-reviewed scientific papers are currently accessible at PubMed database. All scientific publications are listed at the official Avemar Research website.
What is fermented wheat germ extract?
Avemar pulvis, the active ingredient of Avemar products, is made from fermented wheat germ. Wheat germ can be subjected to fermentation with Saccharomyces cerevisiae (baker’s yeast) to yield the important benzoquinones: 2,6 dimethoxy-benzoquinone (DMBQ) and 2-methoxy-benzoquinone (MBQ). These benzoquinones are present in unfermented wheat germ as glycosides. The glycosidase activity, what is present during fermentation, leads to release of the benzoquinones as aglycones.
Following fermentation, the aqueous extract of wheat germ is decanted, and the product is spray-dried, homogenized, encapsulated, and formulated. The dried fermented wheat germ extract is standardized to the methoxy-substituted benzoquinones, DMBQ and MBQ, at a concentration of 0.04%.
Since the invention, significant research has been undertaken – not only in the laboratory, but in laboratory animals and human cancer patients as well.
Avemar is indicated for supplementing the clinical oncological treatments (surgery, radiotherapy, chemotherapy, immunotherapy, etc.) of cancer patients. Avemar is indicated to be taken without interruption before, during the full course and after the completion of oncological treatments. Avemar is recommended at any stage of malignant disease. After surgery, Avemar should be initiated when the patient is able to take oral food without complications for at least 4 days.
It is recommended to start taking Avemar right after the recognition of malignant disease (diagnoses). There is no need to wait for the start of the oncological treatment.
Avemar is indicated to be taken continuously, without interruption. Following the completion of oncological treatments it is indicated to continue taking Avemar – for several years – until complete recovery. If the continuous taking of Avemar is interrupted or suspended for any reason, there is no risk to restart taking it again.
The product is not suitable for use as the sole source of nourishment. Avemar is not a replacement or a substitute for any oncological treatments or drugs!
Avemar is contraindicated during pregnancy and breastfeeding. Avemar is also strictly contraindicated for patients undergoing organ or tissue transplantation. The dietary food should not be consumed by patients suffering from bleeding erosions and/or ulcers of the gastrointestinal tract (stomach and duodenal ulcers), enteritis/colitis (severe inflammations of the gastrointestinal tract) or malabsorption syndrome (serious impairment of absorption). The product is contraindicated in gluten sensitive enteropathies (celiac sprue). The product is also contraindicated for patients with inherited fructose intolerance or with hypersensitivity to any of the components and ingredients of the product.
Yes, diabetics can consume Avemar as well, taking into account the carbohydrate content of the product.
Yes the product can be administered at an age above 2.
Avemar may very infrequently have side effects, such as soft stool, unsettled stomach and nausea.
If the patient takes vitamin C, Avemar should be consumed 2 hours before or after taking of any preparation containing vitamin C. It is expedient to take Avemar at different time from other supplements or drugs.